Serving Australia and NZ
1300 543 373
Loading...

Carfilzomib (PR-171)

Carfilzomib (PR-171)

Quick Overview:

Potential use in Covid-19, coronavirus, SARS-CoV-2, 2019-nCoV research

Product Code: S2853
Supplier: Selleck Chemicals

Potential use in Covid-19, coronavirus, SARS-CoV-2, 2019-nCoV research
Details
Carfilzomib (PR-171) is an irreversible proteasome inhibitor with IC50 of <5 nM in ANBL-6 cells, displayed preferential in vitro inhibitory potency against the ChT-L activity in the β5 subunit, but little or no effect on the PGPH and T-L activities. Potential use in Covid-19, coronavirus, SARS-CoV-2, 2019-nCoV research
Additional Information
Product Name Carfilzomib (PR-171)
Supplier name Selleck Chemicals
Size 5mg,10mg,50mg,100mg,10mM/1mL
Product Type Pathway Inhibitors
CAS No. 868540-17-4
Datasheet URL View Datasheet
Publications Publication List

Images